Literature DB >> 17553224

Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak.

Edmund Y W Seto1, Jeffrey A Soller, John M Colford.   

Abstract

During the Escherichia coli O157:H7 outbreak in 2006 in the United States, the primary strategy to prevent illness was to advise consumers not to eat spinach. No widespread warnings were issued about preventing person-to-person (secondary) transmission. A disease transmission model, fitted to the current data, was used to investigate likely reductions in illnesses that could result from interventions to prevent secondary transmission. The model indicates that exposure to contaminated spinach occurred early in the outbreak and that secondary transmission was similar to that in previous E. coli outbreaks ( 12%). The model also suggests that even a modestly effective strategy to interrupt secondary transmission (prevention of only 2%-3% of secondary illnesses) could result in a reduction of 5%-11% of symptomatic cases. This analysis supports the use of widespread public health messages during outbreaks of E. coli O157:H7 with specific advice on how to interrupt secondary transmission.

Entities:  

Mesh:

Year:  2007        PMID: 17553224     DOI: 10.3201/eid1306.061264

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  9 in total

Review 1.  Escherichia coli O157:H7: animal reservoir and sources of human infection.

Authors:  Witold A Ferens; Carolyn J Hovde
Journal:  Foodborne Pathog Dis       Date:  2010-11-30       Impact factor: 3.171

2.  Examining the role of person-to-person transmission during a verocytotoxigenic Escherichia coli outbreak in Ontario, Canada.

Authors:  Roksolana Hovdey; Jan M Sargeant; David N Fisman; Amy L Greer
Journal:  BMC Res Notes       Date:  2022-05-21

3.  Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin.

Authors:  T Zangari; A R Melton-Celsa; A Panda; M A Smith; I Tatarov; L De Tolla; A D O'Brien
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

4.  Prevention of secondary household transmission during Shiga toxin-producing Escherichia coli outbreaks.

Authors:  K Tokuda; Y Yahata; T Sunagawa
Journal:  Epidemiol Infect       Date:  2016-06-13       Impact factor: 4.434

5.  Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008.

Authors:  Mary E Locking; Kevin G J Pollock; Lesley J Allison; Linda Rae; Mary F Hanson; John M Cowden
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

6.  A Shiga toxin-producing Escherichia coli O157 outbreak associated with consumption of rice cakes in 2011 in Japan.

Authors:  K Nabae; M Takahashi; T Wakui; H Kamiya; K Nakashima; K Taniguchi; N Okabe
Journal:  Epidemiol Infect       Date:  2012-11-06       Impact factor: 4.434

7.  Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres.

Authors:  A Talaminos; L López-Cerero; J Calvillo; A Pascual; L M Roa; J Rodríguez-Baño
Journal:  Epidemiol Infect       Date:  2016-02-03       Impact factor: 4.434

8.  Diarrhoeagenic Escherichia coli in mother-child Pairs in Ile-Ife, South Western Nigeria.

Authors:  Babatunde W Odetoyin; Jennifer Hofmann; Aaron O Aboderin; Iruka N Okeke
Journal:  BMC Infect Dis       Date:  2016-01-25       Impact factor: 3.090

9.  Analysis of enteric disease outbreak metrics, British Columbia Centre for Disease Control, 2005-2014.

Authors:  D Fong; M Otterstatter; M Taylor; E Galanis
Journal:  Can Commun Dis Rep       Date:  2017-01-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.